Cargando…
USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer. TNBC does not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. Cytotoxic chemotherapy and surgery are the current therapeutic strategies for TNBC patients, but the chemore...
Autores principales: | Lin, Yueh-Te, Lin, Joseph, Liu, Yi-En, Chen, Yun-Cen, Liu, Shiang-Ting, Hsu, Kai-Wen, Chen, Dar-Ren, Wu, Han-Tsang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600340/ https://www.ncbi.nlm.nih.gov/pubmed/36291159 http://dx.doi.org/10.3390/cells11203294 |
Ejemplares similares
-
Deubiquitination and stabilization of PTEN by USP13
por: Zhang, Jinsong, et al.
Publicado: (2013) -
Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021) -
USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL
por: Liu, Yi, et al.
Publicado: (2023) -
USP13 negatively regulates antiviral responses by deubiquitinating STING
por: Sun, He, et al.
Publicado: (2017) -
USP27X negatively regulates antiviral signaling by deubiquitinating RIG-I
por: Tao, Xinyue, et al.
Publicado: (2020)